Pacira Pharma (PCRX) Tops Q1 EPS by 8c; EXPAREL Sales Rose 14%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Pacira Pharma (PCRX) Tops Q1 EPS by 8c; EXPAREL Sales Rose 14%

Mizuho Securities Cuts Price Target on Pacira Pharma (PCRX); Sights Conservatism

May 3, 2016 7:22 AM EDT

Mizuho Securities maintained a Buy rating on Pacira Pharmaceuticals (NASDAQ: PCRX), and cut the price target to $64.00 (from $79.00), following the company's 1Q earnings report. PCRX reported revenues of $65.5M and an adjusted EPS of $0.14 vs. the consensus estimates of $66.9M and $0.07. There was... More